Hochschulschrift
Quality assurance of investigator initiated clinical trials in oncology
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Dateien im PDF-Format
Münster (Westfalen), Univ., Diss., 2005
- Keyword
-
Krebs
Onkologie
- Creator
- URN
-
urn:nbn:de:hbz:6-35619550215
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
Guide for investigator initiated trials
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
The development and challenges of Investigator-Initiated Trials (IITs) in China
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Investigator led trials: challenges and opportunities
Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials
Funding multinational investigator-initiated clinical studies in Europe: why and how?
Die Bereitstellung von Daten aus klinischen Prüfungen : Auswirkungen der EU-Clinical Trials Verordnung und des EU-Data Governance Act auf Investigator Initiated Trials (IITs)
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
Guide for investigator initiated trials
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
The development and challenges of Investigator-Initiated Trials (IITs) in China
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Investigator led trials: challenges and opportunities
Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials
Funding multinational investigator-initiated clinical studies in Europe: why and how?
Die Bereitstellung von Daten aus klinischen Prüfungen : Auswirkungen der EU-Clinical Trials Verordnung und des EU-Data Governance Act auf Investigator Initiated Trials (IITs)
Quality assurance of investigator initiated clinical trials in oncology : from protocol development to publication
Guide for investigator initiated trials
Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology
The development and challenges of Investigator-Initiated Trials (IITs) in China
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Investigator initiated trials versus industry sponsored trials - translation of randomized controlled trials into clinical practice (IMPACT)
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design
Investigator led trials: challenges and opportunities
Development of a risk-tailored approach and dashboard for efficient management and monitoring of investigator-initiated trials
Funding multinational investigator-initiated clinical studies in Europe: why and how?